Efficacy and safety of combination PD‐1/PD‐L1 checkpoint inhibitors for malignant solid tumours: A systematic review

Treatment of multiple malignant solid tumours with programmed death (PD)‐1/PD ligand (PD‐L) 1 inhibitors has been reported. However, the efficacy and immune adverse effects of combination therapies are controversial. This meta‐analysis was performed with PubMed, Web of Science, Medline, EMBASE and C...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Qigu, Gu, Lihu, Su, Rong, Chen, Bangsheng, Cao, Hongcui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701512/
https://www.ncbi.nlm.nih.gov/pubmed/33078904
http://dx.doi.org/10.1111/jcmm.15991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701512/
https://www.ncbi.nlm.nih.gov/pubmed/33078904
http://dx.doi.org/10.1111/jcmm.15991

Ejemplares similares